BEYASMIN owner Contact Information online
from Bayer Schering Pharma AG
BEYASMIN
US serial number:85019084
Application filling date:Apr. 21, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Dec. 09, 2013
Publication date:Sep. 07, 2010
Abandoned date:Dec. 09, 2013
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations, namely, hormonal preparations for medical use
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Pharmaceutical preparations
namely
hormonal preparations for medical use
Current owner owner name:Bayer Schering Pharma AG
Current owner owner address:Mullerstrasse 178
Berlin
GERMANY
13353
Current owner legal entity type:CORPORATION
Current owner state or country:GERMANY
Attorney name:Jeffrey M. Gitchel
Attorney email:BayerTrademarkUS@Bayer.com
Attorney email authorized:Yes
Correspondent name address:Jeffrey M. Gitchel
Bayer Corporation
100 Bayer Road
Pittsburgh,
PENNSYLVANIA
UNITED STATES
15205
Correspondent phone:412-777-4860
Correspondent email:BayerTrademarkUS@Bayer.com
Correspondent fax:412-778-4432
Correspondent email authorized:Yes
Domestic representative name:Jeffrey M. Gitchel
Domestic representative phone:412-777-4860
Domestic representative fax:412-778-4432
Domestic representative email:BayerTrademarkUS@Bayer.com
Domestic representative email authorized:Yes
Trademark staff tm attorney:MCBRIDE, THEODORE M
Trademark staff law office assigned BEYASMIN:LAW OFFICE 103
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Syngenta Participations AG (18) Scott Riddell (17)Popular publication dates
Sep. 07, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 12, 2011 Apr. 19, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
